What does SUV uptake on a PET scan mean for CLL

Understanding SUV Uptake on PET Scans in CLL

Great question—this is an important imaging finding that helps your doctors evaluate your disease status.

What SUV Means

SUV stands for "Standardized Uptake Value." Think of it as a measurement of how much glucose (sugar) a lesion or lymph node is consuming on a PET scan. Cancer cells typically consume more glucose than normal cells, so they "light up" more brightly on the scan.

The SUV is expressed as a number—for example, an SUV of 5, 10, or 15. Higher numbers generally mean more metabolic activity (more glucose consumption), which often suggests more aggressive disease.

SUV in CLL: The Key Clinical Question

According to the NCCN Guidelines for Chronic Lymphocytic Leukemia, SUV values become particularly important when doctors are trying to answer one specific question:

Does this patient have Richter transformation?

Richter transformation is when CLL transforms into a more aggressive type of lymphoma called diffuse large B-cell lymphoma (DLBCL). This is a serious complication that occurs in about 2-10% of CLL patients during their disease course.

The SUV Threshold: What's Significant?

The NCCN Guidelines note that an SUVmax (maximum SUV) of ≥10 has been shown to be a valid marker to distinguish Richter transformation from regular CLL, particularly in patients treated with chemotherapy or chemoimmunotherapy.

What this means in practical terms:

• SUV ≥10: May suggest Richter transformation
• SUV <10: More likely to be CLL without transformation

However—and this is important—SUV alone is not definitive. The guidelines emphasize that PET scans have limitations:

"Other studies have reported that SUVmax ≥10 alone lacks both sensitivity and specificity to distinguish Richter transformation from CLL in patients who develop Richter transformation while on ibrutinib."

This means some patients with Richter transformation may have SUV values between 5-10, and some patients without transformation may have higher values.

When SUV Matters Most in Your Care

According to NCCN Guidelines, your doctor should consider a lymph node biopsy (tissue sample) if you have:

• Disease progression on ibrutinib (a BTK inhibitor treatment)
• Elevated LDH (a blood marker)
• Lymphadenopathy (enlarged lymph nodes) without increased lymphocytes in the blood
• An elevated SUV on PET scan

The bottom line: If your PET scan shows an elevated SUV, your oncologist will likely recommend a biopsy of the affected lymph node to confirm whether this represents Richter transformation or just active CLL.

Questions to Ask Your Oncologist

1. What is my specific SUV value, and what does it mean for my situation?
2. Do you recommend a biopsy based on my PET findings?
3. If this is Richter transformation, what treatment options are available?
4. How will you monitor my disease going forward?
5. Are there clinical trials I should consider?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.